Patents by Inventor Deborah Lynn Keefe

Deborah Lynn Keefe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING LICHEN PLANUS USING INTERLEUKIN (IL-17) ANTAGONISTS
    Publication number: 20220403018
    Abstract: The present disclosure relates to methods for treating lichen planus (e.g., lichen planopilaris, mucosal lichen planus, cutaneous lichen planus) using Interleukin (IL)-17 antagonists, e.g., secukinumab. Also disclosed herein are IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating patients having lichen planus (e.g., lichen planopilaris, mucosal lichen planus, cutaneous lichen planus), as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
    Type: Application
    Filed: December 4, 2020
    Publication date: December 22, 2022
    Inventors: Deborah Lynn KEEFE, Elisa MUSCIANISI, Maximilian REINHARDT, Xiaoling WEI, Ruquan (Ryan) YOU
  • SGLT1/2 inhibitor LIK066 for treating obesity
    Patent number: 10952989
    Abstract: The present invention is drawn to methods for effecting weight loss, e.g. in the treatment of obesity and related conditions, including conditions associated with and/or caused by obesity per se.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: March 23, 2021
    Assignee: Novartis AG
    Inventors: Deborah Lynn Keefe, Qing Shao
  • SGLT1/2 INHIBITOR LIK066 FOR TREATING OBESITY
    Publication number: 20200121639
    Abstract: The present invention is drawn to methods for effecting weight loss, e.g.. in the treatment of obesity and related conditions, including conditions associated with and/or caused by obesity per se.
    Type: Application
    Filed: March 2, 2018
    Publication date: April 23, 2020
    Inventors: Deborah Lynn Keefe, Qing SHAO